ArticleTheranostics2021
ILT4 inhibition prevents TAM- and dysfunctional T cell-mediated immunosuppression and enhances the efficacy of anti-PD-L1 therapy in NSCLC with EGFR activation.
Xiaozheng Chen et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
123 papers cite itlatest 60 shown
this papercites it